Johnson & Johnson wins U.S. FDA approval for bladder cancer drug

Johnson& Johnson's drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news